These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1042 related items for PubMed ID: 26005723

  • 1. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, Sun B, Zhang B, Cao W.
    Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.
    Meran S, Luo DD, Simpson R, Martin J, Wells A, Steadman R, Phillips AO.
    J Biol Chem; 2011 May 20; 286(20):17618-30. PubMed ID: 21454519
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.
    Midgley AC, Rogers M, Hallett MB, Clayton A, Bowen T, Phillips AO, Steadman R.
    J Biol Chem; 2013 May 24; 288(21):14824-38. PubMed ID: 23589287
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
    Uttamsingh S, Bao X, Nguyen KT, Bhanot M, Gong J, Chan JL, Liu F, Chu TT, Wang LH.
    Oncogene; 2008 Apr 17; 27(18):2626-34. PubMed ID: 17982486
    [Abstract] [Full Text] [Related]

  • 5. Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling.
    Simpson RM, Wells A, Thomas D, Stephens P, Steadman R, Phillips A.
    Am J Pathol; 2010 Mar 17; 176(3):1215-28. PubMed ID: 20093489
    [Abstract] [Full Text] [Related]

  • 6. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.
    Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR, Cha JH, Jang JW, Bae SH, Jang B, Kim JH, Hur W, Choi JY, Yoon SK.
    Biochem Biophys Res Commun; 2016 Sep 02; 477(4):568-574. PubMed ID: 27320862
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
    Park GB, Ko HS, Kim D.
    Mol Med Rep; 2017 Aug 02; 16(2):1826-1836. PubMed ID: 28627617
    [Abstract] [Full Text] [Related]

  • 9. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
    Watanabe-Takano H, Takano K, Hatano M, Tokuhisa T, Endo T.
    PLoS One; 2015 Aug 02; 10(5):e0127888. PubMed ID: 25996975
    [Abstract] [Full Text] [Related]

  • 10. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H.
    Toxicology; 2014 Aug 01; 322():23-33. PubMed ID: 24793912
    [Abstract] [Full Text] [Related]

  • 11. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J, Liu M, Yang L, Tu G, Zhu Q, Chen M, Cheng H, Luo H, Fu W, Li Z, Yang G.
    Breast Cancer Res; 2015 May 21; 17(1):69. PubMed ID: 25990368
    [Abstract] [Full Text] [Related]

  • 12. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W, Shi W, Bellusci S, Groffen J, Heisterkamp N, Minoo P, Warburton D.
    J Cell Physiol; 2007 Sep 21; 212(3):796-806. PubMed ID: 17516543
    [Abstract] [Full Text] [Related]

  • 13. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.
    Int J Oncol; 2012 Jul 21; 41(1):211-8. PubMed ID: 22552741
    [Abstract] [Full Text] [Related]

  • 14. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
    Tsai PC, Fu YS, Chang LS, Lin SR.
    Toxicon; 2016 Mar 01; 111():108-20. PubMed ID: 26774845
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.
    Tian YC, Chen YC, Chang CT, Hung CC, Wu MS, Phillips A, Yang CW.
    Exp Cell Res; 2007 Jul 01; 313(11):2367-77. PubMed ID: 17467690
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao WH, Liu XY, Wang Y, Yang ZC, Xu HM, Wang HB.
    Oncol Rep; 2013 Jan 01; 29(1):219-25. PubMed ID: 23129177
    [Abstract] [Full Text] [Related]

  • 17. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.
    Hepatology; 2013 Oct 01; 58(4):1349-61. PubMed ID: 23696034
    [Abstract] [Full Text] [Related]

  • 18. Tumour necrosis factor-stimulated gene (TSG)-6 controls epithelial-mesenchymal transition of proximal tubular epithelial cells.
    Bommaya G, Meran S, Krupa A, Phillips AO, Steadman R.
    Int J Biochem Cell Biol; 2011 Dec 01; 43(12):1739-46. PubMed ID: 21864707
    [Abstract] [Full Text] [Related]

  • 19. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
    Gao J, Yan Q, Wang J, Liu S, Yang X.
    J Cell Physiol; 2015 Apr 01; 230(4):775-82. PubMed ID: 25205054
    [Abstract] [Full Text] [Related]

  • 20. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H, Jeon H, Lee D, Choi HK, Kang KS, Choi KC.
    Bioorg Med Chem Lett; 2015 Dec 01; 25(23):5508-13. PubMed ID: 26508552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.